Anti-IL-21 monoclonal antibody combined with liraglutide effectively reverses established hyperglycemia in mouse models of type 1 diabetes. [electronic resource]
Producer: 20180531Description: 65-74 p. digitalISSN:- 1095-9157
- Animals
- Antibodies, Monoclonal -- therapeutic use
- Diabetes Mellitus, Type 1 -- immunology
- Disease Models, Animal
- Drug Therapy, Combination
- Female
- Humans
- Hyperglycemia -- immunology
- Immunotherapy -- methods
- Insulin -- genetics
- Insulin-Secreting Cells -- immunology
- Interleukins -- immunology
- Liraglutide -- therapeutic use
- Mice
- Mice, Inbred NOD
- Mice, Transgenic
- Interleukin-21
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.